chevron_leftBack
As of 7 June 2026, Indo-Bangla Pharmaceuticals Ltd. has a market cap of $12.22M USD, ranking #40193 globally and #248 in Bangladesh.
It ranks #3584 in the Healthcare sector, and #1168 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$12.22MUSD
1.5B BDT
Enterprise Value
$12.35MUSD
1.52B BDT
Revenue (TTM)
$1.8MUSD
221.18M BDT
EBITDA (TTM)
$116.53KUSD
14.31M BDT
Net Income (TTM)
-$209.02KUSD
-25.64M BDT
EBITDA Margin
6.5%
Profit Margin
-12%
PS Ratio
6.8
PB Ratio
1.0
EV/EBITDA
106.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
A. F. M. Huq
open_in_new
Employees
127
Founded
1954
Website
indo-banglapharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.2% | -5.3% | -7.4% | 5.9% | 12% | 25% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
IBP
Indo-Bangla Pharmaceuticals Ltd Ordinary Shares
ISIN: BD0494IBPL08
Shares Out.:
Shares Outstanding:
116.205M1
|
12.90 BDT |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Indo-Bangla Pharmaceuticals Ltd.
Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. The company’s principal products include Omeprazole, Esomeprazole, Dexamethasone, Domperidone, Metronidazole, Montelukast, Paracetamol, Sildenafil Citrate, and several other formulations. It markets its products in various forms, such as tablets, capsules. Indo-Bangla Pharmaceuticals Limited was founded in 1954 and is based in Dhaka, Bangladesh.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
DSE: SQURPHARMA
|
$1.54B
13K%
189.43B BDT
|
7.3
|
|
DSE: BXPHARMA
|
$417.54M
3K%
51.21B BDT
|
8.1
|
|
DSE: RENATA
|
$389.85M
3K%
47.82B BDT
|
18.9
|
|
DSE: UNILEVERCL
|
$326.4M
3K%
40.03B BDT
|
55.4
|
|
DSE: BEACONPHAR
|
$194.17M
1K%
23.82B BDT
|
19.2
|
|
DSE: ACI
|
$145.51M
1K%
17.85B BDT
|
154.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
6M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
4M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
3M%
|
97.4
|
|
SIX: RO
|
$324.68B
3M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
2M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
2M%
218.9B CHF
|
20.5
|
chevron_leftBack